BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 20952439)

  • 1. The pathogenesis of idiopathic pulmonary fibrosis.
    Coward WR; Saini G; Jenkins G
    Ther Adv Respir Dis; 2010 Dec; 4(6):367-88. PubMed ID: 20952439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis.
    Goodwin A; Jenkins G
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):849-54. PubMed ID: 19614606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
    Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
    Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
    Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
    Fernandez IE; Eickelberg O
    Proc Am Thorac Soc; 2012 Jul; 9(3):111-6. PubMed ID: 22802283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha.
    Kapanci Y; Desmouliere A; Pache JC; Redard M; Gabbiani G
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2163-9. PubMed ID: 8520791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IPF: new insight on pathogenesis and treatment.
    Harari S; Caminati A
    Allergy; 2010 May; 65(5):537-53. PubMed ID: 20121758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology.
    Vancheri C
    Proc Am Thorac Soc; 2012 Jul; 9(3):153-7. PubMed ID: 22802290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?
    Ruan W; Ying K
    Pathol Res Pract; 2010 Aug; 206(8):537-43. PubMed ID: 20452131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells.
    Malizia AP; Lacey N; Walls D; Egan JJ; Doran PP
    Exp Cell Res; 2009 Jul; 315(11):1819-31. PubMed ID: 19361498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
    Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?
    Mahendran S; Sethi T
    QJM; 2012 Oct; 105(10):929-34. PubMed ID: 22647761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Salton F; Volpe MC; Confalonieri M
    Medicina (Kaunas); 2019 Mar; 55(4):. PubMed ID: 30925805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Family with Sequence Similarity 13, Member A Exacerbates Pulmonary Fibrosis Potentially by Promoting Epithelial to Mesenchymal Transition.
    Rahardini EP; Ikeda K; Nugroho DB; Hirata KI; Emoto N
    Kobe J Med Sci; 2020 Jan; 65(3):E100-E109. PubMed ID: 32029695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor and lung fibrosis.
    Crestani B; Marchand-Adam S; Quesnel C; Plantier L; Borensztajn K; Marchal J; Mailleux A; Soler P; Dehoux M
    Proc Am Thorac Soc; 2012 Jul; 9(3):158-63. PubMed ID: 22802291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.